Leadership
Niagen Bioscience unites Nobel laureates, pioneering researchers, global business leaders, and consumer health innovators to advance NAD+ research through precision science and market-leading expertise.
Management
Robert Fried
Chief Executive Officer
Robert Fried drives innovation in healthspan science and wellness, building and leading transformative ventures.
Michiko Kelley
Chief Marketing Officer
Michiko Kelley, a proven marketing leader, drives growth and innovation in consumer and medical tech.
Ozan Pamir
Chief Financial Officer
Ozan Pamir brings over a decade of expertise in life sciences finance, corporate strategy, capital markets, and funding.
Andrew Shao, Ph.D.
SVP, Global Regulatory & Scientific Affairs
Dr. Andrew Shao serves as SVP at Niagen Bioscience with a Ph.D. from Tufts University and oversees scientific, technical and regulatory functions.
Carlos Lopez
SVP, General Counsel
Carlos Lopez is a legal expert and executive leader in dietary supplements and natural products.
Scientific Advisory Board
Charles Brenner, Ph.D.
Chief Scientific Advisor
Dr. Charles Brenner is a leading global researcher in NAD+ metabolism, known for discovering the vitamin activity of nicotinamide riboside.
Roger Kornberg, Ph.D., Nobel Prize Winner
Chairman
Dr. Roger Kornberg, a Stanford professor, won the 2006 Nobel Prize for his work on eukaryotic transcription.
Dr. Vilhelm (Will) Bohr, M.D., Ph.D., D.Sc.
Member
Dr. Vilhelm Bohr's work has advanced DNA repair, aging, and neurodegenerative disease research.
Brunie Felding, Ph.D.
Member
Dr. Brunie Felding, a Principal Investigator at the Scripps Research Institute studies breast cancer metastasis and NAD+ metabolism.
Dr. Rudolph Tanzi, Ph.D.
Member
Dr. Rudolph Tanzi, a Harvard neuroscientist, co-discovered many key Alzheimer’s disease genes and created the first human brain organoid models of Alzheimer’s, which he has used to develop novel therapeutics.
Bruce German, Ph.D.
Member
Dr. Bruce German, a UC Davis professor, researches milk science, food structures, and personalized nutrition.
Board of Directors
Robert Fried
Chief Executive Officer
Robert Fried drives innovation in healthspan science and wellness, building and leading transformative ventures.
Frank L. Jaksch Jr.
Co-Founder, Chairman of the Board
Frank L. Jaksch Jr., Niagen Bioscience (Formerly ChromaDex) co-founder, leads research and strategy in pharma and nutraceuticals.
Steven D. Rubin
Non-Executive Director
Steven D. Rubin, a corporate executive and attorney, serves on multiple biotech and healthcare boards.
Wendy Yu
Non-Executive Director
Wendy Yu leads digital strategy and Asia expansion for Horizons Digital Group and its portfolio companies.
Gary Ng
Non-Executive Director
Gary Ng, Project Director at Horizon Ventures, brings retail expertise from leadership roles at AS Watson Group and major brands.
Ann Cohen
Non-Executive Director
Ann Cohen, EVP and CFO of The IIA, has deep expertise in finance, risk management, and accounting.
Kristin Patrick
Non-Executive Director
Kristin Patrick, President & CMO at Marc Jacobs, brings brand transformation expertise from Gap, Revlon, Pepsi, and leading firms.
Hamed Shahbazi
Non-Executive Director
Hamed Shahbazi, a tech entrepreneur, advances digital health, M&A strategy, and impact investing.
Science Leadership
Andrew Shao, Ph.D.
SVP, Global Regulatory & Scientific Affairs
Dr. Andrew Shao serves as SVP at Niagen Bioscience with PhD from Tufts University and oversees scientific, technical and regulatory functions.
Aron Erickson
VP of Research & Development
Aron Erickson, VP of Research and Development, brings 20 years in chemistry expertise to Niagen Bioscience.
Albert Rembert
VP of Quality & Product Safety
Albert Rembert leads quality at Niagen Bioscience, 25+ years expert, Navy veteran, Chemical Engineer, drives global compliance.
Yasmeen Nkrumah-Elie, Ph.D.
Global Director of External Research at Niagen Bioscience
Dr. Yasmeen Nkrumah-Elie leads global preclinical and clinical research development for Niagen Bioscience, FAMU Ph.D. in Pharmaceuticals Science with experience in molecular nutrition and metabolomics.
Mona Rosene, MS, RD
Global Director, Scientific & Medical Affairs
Mona Rosene, MS, RD, is a nutrition expert leading Scientific & Medical Affairs at Niagen Bioscience, focusing on cellular health and NAD+ research.
Erika Shioya
Global Director of Regulatory Affairs
Erika Shioya directs Global Regulatory Affairs at ChromaDex, 15+ years expert, UC Berkeley graduate, sustainability advocate, compliance leader.